[1]張莉忠,王義圍.高血壓動脈硬化患者軀體化癥狀相關因素分析[J].醫學信息,2020,(04):106-108.[doi:10.3969/j.issn.1006-1959.2020.04.032]
 ZHANG Li-zhong,WANG Yi-wei.Analysis on the Related Factors of Somatization Symptoms in Patients with Hypertension Arteriosclerosis[J].Medical Information,2020,(04):106-108.[doi:10.3969/j.issn.1006-1959.2020.04.032]
點擊復制

高血壓動脈硬化患者軀體化癥狀相關因素分析()
分享到:

醫學信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期數:
2020年04期
頁碼:
106-108
欄目:
臨床研究
出版日期:
2020-02-15

文章信息/Info

Title:
Analysis on the Related Factors of Somatization Symptoms in Patients with Hypertension Arteriosclerosis
文章編號:
1006-1959(2020)04-0106-03
作者:
張莉忠王義圍
(承德醫學院附屬醫院老年病科,河北 承德 067000)
Author(s):
ZHANG Li-zhongWANG Yi-wei
(Department of Geriatrics,the Affiliated Hospital of Chengde Medical College,Chengde 067000,Hebei,China)
關鍵詞:
高血壓動脈硬化軀體化癥狀臂踝脈搏波傳導速度踝臂指數
Keywords:
HypertensionArteriosclerosisSomatization symptomsBrachial-ankle pulse wave velocityAnkle-brachial index
分類號:
R544.1
DOI:
10.3969/j.issn.1006-1959.2020.04.032
文獻標志碼:
A
摘要:
目的 探討高血壓動脈硬化患者軀體化癥狀的情況及相關危險因素。方法 回顧性分析2019年3月~9月我院收治的131例高血壓動脈硬化患者臨床資料,均進行臂踝脈搏波傳導速度(baPWV)和踝臂指數(ABI)檢測,并采用軀體化癥狀自評量表進行評分,根據是否存在軀體化癥狀分為軀體化癥狀組(37例)和無軀體化癥狀組(94例),比較兩組臨床資料,并分析高血壓動脈硬化患者軀體化癥狀的相關危險因素。結果 兩組舒張壓、高密度脂蛋白、尿酸、肌酐比較,差異有統計學意義(P<0.05),而年齡、體質指數、收縮壓、空腹血糖、總膽固醇、甘油三酯、低密度脂蛋白、血漿同型半胱氨酸比較,差異無統計學意義(P>0.05)。Logistic回歸分析顯示,舒張壓、尿酸是高血壓動脈硬化患者軀體化癥狀的影響因素(P<0.05)。結論 部分高血壓動脈硬化患者存在軀體化癥狀,舒張壓、尿酸與高血壓動脈硬化軀體化癥狀的發生相關。
Abstract:
Objective To investigate the somatization symptoms and related risk factors in patients with hypertension arteriosclerosis.Methods 131 patients with hypertension arteriosclerosis admitted in our hospital from March to September 2019,which were tested for brachial-ankle pulse wave velocity (baPWV) and ankle-brachial index (ABI),and were assessed with somatization symptom checklist. The scores are divided into somatization symptoms group (37 cases) and no somatization symptoms group (94 cases) according to the presence or absence of somatization symptoms.The clinical data between the two groups were compared, and related factors in patients with hypertension arteriosclerosis are analyzed. Results There was a statistically significant difference in diastolic blood pressure, high density lipoprotein, uric acid, and creatinine between the two groups (P<0.05);but there was no significant difference in age, body mass index, fasting blood glucose, total cholesterol, triglyceride, low-density lipoprotein and plasma homocysteine between the two groups (P>0.05).Logistic regression analysis showed that diastolic blood pressure and uric acid were the influencing factors of somatization symptoms in patients with hypertension arteriosclerosis.Conclusion Some patients with hypertension arteriosclerosis have somatization symptoms. Diastolic blood pressure and uric acid are related to the occurrence of somatization symptoms of hypertension arteriosclerosis.

參考文獻/References:

[1]中國高血壓防治指南修訂委員會,高血壓聯盟(中國),中華醫學會心血管病學分會,等.中國高血壓防治指南(2018年修訂版)[J].中國心血管雜志,2019,24(1):24-56. [2]Townsend RR,Wilkinson IB,Schiffrin EL,et al.Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness:A Scientific Statement From the American Heart Association[J].Hypertension,2015,66(3):698-722. [3]Aboyans V,Ricco JB,Bartelink M,et al.2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases,in collaboration with the European Society for Vascular Surgery (ESVS)[J].Rev Esp Cardiol(Engl Ed),2018,71(2):111. [4]中華醫學會神經病學分會神經心理學與行為神經病學組.綜合醫院焦慮、抑郁與軀體化癥狀診斷治療的專家共識[J].中華神經科雜志,2016,49(12):908-917. [5]Liu Y,Zhao J,Fan X,et al.Dysfunction in Serotonergic and Noradrenergic Systems and Somatic Symptoms in Psychiatric Disorders[J].Front Psychiatry,2019,10:286. [6]Carney RM,Freedland KE.Depression and coronary heart disease[J].Nat Rev Cardiol,2017,14(3):145-155. [7]Chen Y,Xu B,Sun W,et al.Impact of the Serum Uric Acid Level on Subclinical Atherosclerosis in Middle-aged and Elderly Chinese[J].Journal of Atherosclerosis and Thrombosis,2015,22(8):823-832.

相似文獻/References:

[1]顏 明,龔麗娜,王淑清.彩超在高血壓患者腎動脈血流動力學檢測中的應用分析[J].醫學信息,2018,(02):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
 YAN Ming,GONG Li-na,WANG Shu-qing.Application of Color Doppler Ultrasound in the Measurement of Renal Artery Hemodynamics in Patients with Hypertension[J].Medical Information,2018,(04):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
[2]夏能能,任 薇,杜建平,等.1953~2016年中醫藥治療高血壓領域研究熱點分析[J].醫學信息,2018,(04):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
 XIA Neng-neng,REN Wei,DU Jian-ping,et al.Analysis of Hot Spots in the Research of Traditional Chinese Medicine in Treating Hypertension from 1953 to 2016[J].Medical Information,2018,(04):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
[3]靳雪芹,鄧正聰.代謝綜合征與腫瘤關系的研究進展[J].醫學信息,2018,(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
 JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,(04):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[4]喬 君,高 翔,王 瑜,等.纈沙坦對原發性高血壓患者外周PBMC中IL-17表達的影響[J].醫學信息,2018,(07):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
 QIAO Jun,GAO Xiang,WANG Yu,et al.The Effect of Valsartan on the Expression of IL-17 in Peripheral PBMC of Patients with Essential Hypertension[J].Medical Information,2018,(04):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
[5]董巧玲.健康教育對原發性高血壓患者治療效果的影響[J].醫學信息,2018,(09):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
 DONG Qiao-ling.Effect of Health Education on Treatment of Patients with Essential Hypertension[J].Medical Information,2018,(04):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
[6]沈 正,王慶海.焦慮抑郁障礙與血壓變異性研究[J].醫學信息,2018,(16):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
 SHEN Zheng,WANG Qing-hai.Study on Anxiety and Depression Disorder and Blood Pressure Variability[J].Medical Information,2018,(04):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
[7]左洪亮.苯磺酸左旋氨氯地平片治療中老年患者 輕中度原發性高血壓的療效觀察[J].醫學信息,2018,(16):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
 ZUO Hong-liang.Efficacy of Levamlodipine Besylate Tablets in Treatment of Mild to Moderate Essential Hypertension in Middle-aged and Elderly Patients[J].Medical Information,2018,(04):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
[8]袁 敏,周袁成.鈣離子拮抗劑類降壓藥的臨床應用與不良反應分析[J].醫學信息,2018,(17):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
 YUAN Min,ZHOU Yuan-cheng.Clinical Application and Adverse Reaction Analysis of Calcium Antagonist Antihypertensive Drugs[J].Medical Information,2018,(04):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
[9]陳學軍,李 敏,張 丹,等.社區一體化分級管理模式對社區老年高血壓患者的管理效果[J].醫學信息,2018,(18):169.[doi:10.3969/j.issn.1006-1959.2018.18.055]
 CHEN Xue-jun,LI Min,ZHANG Dan,et al.Management Effect of Community Integration Hierarchical Management Mode on Elderly Hypertensive Patients in Community[J].Medical Information,2018,(04):169.[doi:10.3969/j.issn.1006-1959.2018.18.055]
[10]張莉莉.左旋氨氯地平和氨氯地平治療輕中度高血壓臨床效果觀察[J].醫學信息,2018,(21):149.[doi:10.3969/j.issn.1006-1959.2018.21.043]
 ZHANG Li-li.Clinical Efficacy of Levamlodipine and Amlodipine in Treatment of Mild to Moderate Hypertension[J].Medical Information,2018,(04):149.[doi:10.3969/j.issn.1006-1959.2018.21.043]

更新日期/Last Update: 2020-02-15
中国足彩网竞彩 大乐透复式中奖投注图 深圳风采2019开奖查询 时时彩模拟投注安卓版 湖北快3走势图表 北京十一选五前三直走势图一定牛 加拿大28开奖官网 手机photoshop软件 盛鹏配资 平码独平 公式规律 手机版天津11选5走势图